Latest Research & Analysis

31-Oct-2014 - Probes Reporter Perspective reports identify and summarize those SEC-related risk factors that we believe hold the potential to destabilize a company, distract its management, and/or interfere with underlying fundamentals. Our reports otherwise take no view on a public company’s...

31-Oct-2014 - The Probes Reporter™ FOIA Update is designed to let you know of new documents and information we recently received from the SEC in response to our Freedom of Information Act requests, appeals, and follow-up activities.  At present, this report is posted in real-time for...

31-Oct-2014 - The Probes Reporter™ FOIA Update is designed to let you know of new documents and information we recently received from the SEC in response to our Freedom of Information Act requests, appeals, and follow-up activities.  At present, this report is posted in real-time for...

31-Oct-2014 - The Probes Reporter™ FOIA Update is designed to let you know of new documents and information we recently received from the SEC in response to our Freedom of Information Act requests, appeals, and follow-up activities.  At present, this report is posted in real-time for...

24-Oct-2014 - The Probes Reporter™ FOIA Update is designed to let you know of new documents and information we recently received from the SEC in response to our Freedom of Information Act requests, appeals, and follow-up activities.  At present, this report is posted in real-time for free....

9-Oct-2014 - The Probes Reporter™ Watch List tracks those companies involved in undisclosed SEC investigative activity.  Names are added to and removed from this list frequently based on responses we received to Freedom of Information Act (FOIA) requests we file with the SEC.  This is...

2-Oct-2014 - Whether or not you agree with the Foreign Corrupt Practices Act, it is the law here in the US and violating the same can get you in trouble.  If you're one of the many inclined to quickly dismiss, or even pooh-pooh FCPA investigations as little more than "nuisances" posing no...

25-Sep-2014 - Based on new information received from the SEC, we are removing Regeneron Pharmaceuticals, Inc. (REGN) from our Watch List. 17-Sep-2014:  In response to an appeal we filed with the SEC's Office of the General Counsel, the SEC has now informed us there are no records...

Pages